Short Interest in Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Decreases By 9.7%

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totalling 55,100 shares, a decrease of 9.7% from the December 31st total of 61,000 shares. Based on an average trading volume of 175,200 shares, the days-to-cover ratio […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom , ,Millennium Management ,Raymond James Financial Services Advisors Inc ,Galmed Pharmaceuticals Ltd ,Galmed Pharmaceuticals Company Profile ,Cambridge Investment Research Advisors Inc ,Galmed Pharmaceuticals ,Walleye Capital ,Nasdaq ,Galmed Pharmaceuticals Stock Down ,News Ratings For Galmed Pharmaceuticals Daily ,Get Free Report ,Investment Research Advisors ,Raymond James Financial Services Advisors ,James Financial Services Advisors ,Pharmaceuticals Stock Down ,Pharmaceuticals Ltd ,Galmed Pharmaceuticals Daily ,Nasdaq Glmd ,Glmd ,Medical ,Stocks ,Options ,Put ,Call ,